Baseline FDG PET/CT in free breathing versus deep inspiration breath-hold for pediatric patients with mediastinal lymphoma.


Journal

Acta oncologica (Stockholm, Sweden)
ISSN: 1651-226X
Titre abrégé: Acta Oncol
Pays: England
ID NLM: 8709065

Informations de publication

Date de publication:
Feb 2022
Historique:
pubmed: 18 9 2021
medline: 5 2 2022
entrez: 17 9 2021
Statut: ppublish

Résumé

The prospective TEDDI protocol investigates the feasibility of radiotherapy delivery in deep inspiration breath-hold (DIBH) for pediatric patients. To secure optimal radiotherapy planning, a diagnostic baseline FDG PET/CT in free breathing (FB) and DIBH was acquired. The anatomical changes in the mediastinum and the effect on PET metrics between the two breathing conditions were assessed for pediatric patients with mediastinal lymphoma. Ten patients aged 5-17 were included and had a PET/CT in FB and DIBH. Metabolic active lymphoma volumes were manually delineated with a visually based segmentation method and the PET metrics were extracted. The anatomical lymphoma, lung and heart volumes were delineated on CT. The lung volume increased while the heart was displaced caudally and separated from the lymphoma in DIBH compared to FB. Both the anatomical and the metabolically active lymphoma volumes appeared different regarding shape and configuration in the two breathing conditions. The image quality of the DIBH PET was equal to the FB PET regarding interpretation and delineation of lymphoma lesions. All PET metrics increased on the DIBH PET compared to the FB PET with the highest increase observed for the maximum standardized uptake value (33%, range 7-56%). Diminished respiratory motion together with anatomical changes within the lymphoma increased all PET metrics in DIBH compared to FB. The anatomical changes observed in DIBH compared to FB are expected to reduce radiation doses to the heart and lungs in pediatric patients with mediastinal lymphoma referred for radiotherapy delivery in DIBH and, thereby, reduce their risk of late effects. The Danish Ethical Committee (H-16035870, approved November 24

Identifiants

pubmed: 34533416
doi: 10.1080/0284186X.2021.1974554
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Banques de données

ClinicalTrials.gov
['NCT03315546']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

239-246

Auteurs

Anni Young Lundgaard (AY)

Section of Radiotherapy, Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Danijela Dejanovic (D)

Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Anne Kiil Berthelsen (AK)

Section of Radiotherapy, Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Flemming Littrup Andersen (FL)

Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Laura Ann Rechner (LA)

Section of Radiotherapy, Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Lise Borgwardt (L)

Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Lisa Lyngsie Hjalgrim (LL)

Department of Pediatric Haematology and Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Lena Specht (L)

Section of Radiotherapy, Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Maja Vestmø Maraldo (MV)

Section of Radiotherapy, Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH